Companies seeking an extension to their EU-wide drug’s patent protection, should base their calculations on the time of market authorization in Switzerland if that predated…
Blueprint North America, a Toronto, Canada-based nonprofit that builds and operates globally used proteomic databases, on May 2 laid off half of its 65 staff.…
On March 31, the European Commission (EC) proposed to raise fees for the authorization of pharmaceuticals at the European Medicines Agency (EMEA). Although the agency…
Future revenues of many biotech companies are at significant risk because of new US government powers to lower the costs of drugs administered by physicians…
Starting April 1, researchers in Sweden will be able to legally clone human cells for therapeutic purposes, like their UK colleagues. On February 2, an…
The California Supreme Court on 2 February reopened a legal battle between the City of Hope hospital in Duarte, California, and San Francisco-based Genentech Inc.…
The Munich-based European Patent Office (EPO), at the end of January,dealt fresh blows to Myriad Genetics’ controversial monopoly on diagnostic testing for mutations in human…
On January 18, German proteomics company Biobase tripled in size overnight by acquiring a database subsidiary of Incyte of Wilmington, Delaware, known as Proteome of…
A leading investment advisor to the British government is due to publish a report, this month, on whether the UK should relax its rules on…
Top managers in the biggest biotechnology companies collected bonuses in 2003 52% higher than the year before, resulting in their paycheck increasing by 11%, according…